Five or more years of survival in patients with primary systemic amyloidosis and biopsy-proven cardiac involvement.
Survival of > or =5 years was seen in 8 of 153 patients (5%) with primary systemic amyloidosis and cardiac involvement. All patients with survival of >5 years received chemotherapy and all but 1 had an objective chemotherapeutic response.